Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.

<h4>Background</h4>The architectural transcription factor High Mobility Group-A1 (HMGA1) binds to the minor groove of AT-rich DNA and forms transcription factor complexes ("enhanceosomes") that upregulate expression of select genes within the inflammatory cascade during critica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rebecca M Baron, Silvia Lopez-Guzman, Dario F Riascos, Alvaro A Macias, Matthew D Layne, Guiying Cheng, Cailin Harris, Su Wol Chung, Raymond Reeves, Ulrich H von Andrian, Mark A Perrella
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
R
Q
Acceso en línea:https://doaj.org/article/fb4208f660984133b0e2ed0d972ca126
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fb4208f660984133b0e2ed0d972ca126
record_format dspace
spelling oai:doaj.org-article:fb4208f660984133b0e2ed0d972ca1262021-12-02T20:21:40ZDistamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.1932-620310.1371/journal.pone.0010656https://doaj.org/article/fb4208f660984133b0e2ed0d972ca1262010-05-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20498830/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The architectural transcription factor High Mobility Group-A1 (HMGA1) binds to the minor groove of AT-rich DNA and forms transcription factor complexes ("enhanceosomes") that upregulate expression of select genes within the inflammatory cascade during critical illness syndromes such as acute lung injury (ALI). AT-rich regions of DNA surround transcription factor binding sites in genes critical for the inflammatory response. Minor groove binding drugs (MGBs), such as Distamycin A (Dist A), interfere with AT-rich region DNA binding in a sequence and conformation-specific manner, and HMGA1 is one of the few transcription factors whose binding is inhibited by MGBs.<h4>Objectives</h4>To determine whether MGBs exert beneficial effects during endotoxemia through attenuating tissue inflammation via interfering with HMGA1-DNA binding and modulating expression of adhesion molecules.<h4>Methodology/principal findings</h4>Administration of Dist A significantly decreased lung and liver inflammation during murine endotoxemia. In intravital microscopy studies, Dist A attenuated neutrophil-endothelial interactions in vivo following an inflammatory stimulus. Endotoxin induction of P-selectin expression in lung and liver tissue and promoter activity in endothelial cells was significantly reduced by Dist A, while E-selectin induction was not significantly affected. Moreover, Dist A disrupted formation of an inducible complex containing NF-kappaB that binds an AT-rich region of the P-selectin promoter. Transfection studies demonstrated a critical role for HMGA1 in facilitating cytokine and NF-kappaB induction of P-selectin promoter activity, and Dist A inhibited binding of HMGA1 to this AT-rich region of the P-selectin promoter in vivo.<h4>Conclusions/significance</h4>We describe a novel targeted approach in modulating lung and liver inflammation in vivo during murine endotoxemia through decreasing binding of HMGA1 to a distinct AT-rich region of the P-selectin promoter. These studies highlight the ability of MGBs to function as molecular tools for dissecting transcriptional mechanisms in vivo and suggest alternative treatment approaches for critical illness.Rebecca M BaronSilvia Lopez-GuzmanDario F RiascosAlvaro A MaciasMatthew D LayneGuiying ChengCailin HarrisSu Wol ChungRaymond ReevesUlrich H von AndrianMark A PerrellaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 5, p e10656 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Rebecca M Baron
Silvia Lopez-Guzman
Dario F Riascos
Alvaro A Macias
Matthew D Layne
Guiying Cheng
Cailin Harris
Su Wol Chung
Raymond Reeves
Ulrich H von Andrian
Mark A Perrella
Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.
description <h4>Background</h4>The architectural transcription factor High Mobility Group-A1 (HMGA1) binds to the minor groove of AT-rich DNA and forms transcription factor complexes ("enhanceosomes") that upregulate expression of select genes within the inflammatory cascade during critical illness syndromes such as acute lung injury (ALI). AT-rich regions of DNA surround transcription factor binding sites in genes critical for the inflammatory response. Minor groove binding drugs (MGBs), such as Distamycin A (Dist A), interfere with AT-rich region DNA binding in a sequence and conformation-specific manner, and HMGA1 is one of the few transcription factors whose binding is inhibited by MGBs.<h4>Objectives</h4>To determine whether MGBs exert beneficial effects during endotoxemia through attenuating tissue inflammation via interfering with HMGA1-DNA binding and modulating expression of adhesion molecules.<h4>Methodology/principal findings</h4>Administration of Dist A significantly decreased lung and liver inflammation during murine endotoxemia. In intravital microscopy studies, Dist A attenuated neutrophil-endothelial interactions in vivo following an inflammatory stimulus. Endotoxin induction of P-selectin expression in lung and liver tissue and promoter activity in endothelial cells was significantly reduced by Dist A, while E-selectin induction was not significantly affected. Moreover, Dist A disrupted formation of an inducible complex containing NF-kappaB that binds an AT-rich region of the P-selectin promoter. Transfection studies demonstrated a critical role for HMGA1 in facilitating cytokine and NF-kappaB induction of P-selectin promoter activity, and Dist A inhibited binding of HMGA1 to this AT-rich region of the P-selectin promoter in vivo.<h4>Conclusions/significance</h4>We describe a novel targeted approach in modulating lung and liver inflammation in vivo during murine endotoxemia through decreasing binding of HMGA1 to a distinct AT-rich region of the P-selectin promoter. These studies highlight the ability of MGBs to function as molecular tools for dissecting transcriptional mechanisms in vivo and suggest alternative treatment approaches for critical illness.
format article
author Rebecca M Baron
Silvia Lopez-Guzman
Dario F Riascos
Alvaro A Macias
Matthew D Layne
Guiying Cheng
Cailin Harris
Su Wol Chung
Raymond Reeves
Ulrich H von Andrian
Mark A Perrella
author_facet Rebecca M Baron
Silvia Lopez-Guzman
Dario F Riascos
Alvaro A Macias
Matthew D Layne
Guiying Cheng
Cailin Harris
Su Wol Chung
Raymond Reeves
Ulrich H von Andrian
Mark A Perrella
author_sort Rebecca M Baron
title Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.
title_short Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.
title_full Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.
title_fullStr Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.
title_full_unstemmed Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.
title_sort distamycin a inhibits hmga1-binding to the p-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/fb4208f660984133b0e2ed0d972ca126
work_keys_str_mv AT rebeccambaron distamycinainhibitshmga1bindingtothepselectinpromoterandattenuateslungandliverinflammationduringmurineendotoxemia
AT silvialopezguzman distamycinainhibitshmga1bindingtothepselectinpromoterandattenuateslungandliverinflammationduringmurineendotoxemia
AT dariofriascos distamycinainhibitshmga1bindingtothepselectinpromoterandattenuateslungandliverinflammationduringmurineendotoxemia
AT alvaroamacias distamycinainhibitshmga1bindingtothepselectinpromoterandattenuateslungandliverinflammationduringmurineendotoxemia
AT matthewdlayne distamycinainhibitshmga1bindingtothepselectinpromoterandattenuateslungandliverinflammationduringmurineendotoxemia
AT guiyingcheng distamycinainhibitshmga1bindingtothepselectinpromoterandattenuateslungandliverinflammationduringmurineendotoxemia
AT cailinharris distamycinainhibitshmga1bindingtothepselectinpromoterandattenuateslungandliverinflammationduringmurineendotoxemia
AT suwolchung distamycinainhibitshmga1bindingtothepselectinpromoterandattenuateslungandliverinflammationduringmurineendotoxemia
AT raymondreeves distamycinainhibitshmga1bindingtothepselectinpromoterandattenuateslungandliverinflammationduringmurineendotoxemia
AT ulrichhvonandrian distamycinainhibitshmga1bindingtothepselectinpromoterandattenuateslungandliverinflammationduringmurineendotoxemia
AT markaperrella distamycinainhibitshmga1bindingtothepselectinpromoterandattenuateslungandliverinflammationduringmurineendotoxemia
_version_ 1718374144794427392